Semantic Scholar Open Access 2024 27 sitasi

Heparin-functionalized Cu-based metal-organic framework: An efficient active and passive targeting nanocarrier for anticancer doxorubicin drug delivery.

Sima Darvishi Hossein Hosseinzadeh Fahimeh Kazeminava Amin Mahoutforoush Mohammadreza Tajik +4 lainnya

Abstrak

In this study, by innovative combining the unique characteristics of Cu-based metal-organic framework (MOF) with the versatile attributes of saccharides (i.e., heparin, Hep), a promising approach is established for active and passive targeting DDS, Cu-MOF/Hep, with a pH-controlled release profile and enhanced drug efficacy. The characterization of the synthesized materials (i.e., FT-IR, XRD, SEM, EDX, TEM, DLS, and TGA) confirms the successful synthesis of Cu-MOF/Hep. In vitro studies concerning the loading and release of DOX observed that a higher amount of DOX was released at pH 5 (>90 % on 96 h, 41 °C) compared to pH 7.4 (<10 % on 96 h, 37 °C). The sensitive feature of the used MOF to the pH conditions increased the drug release in environmental conditions similar to cancer tissues. Furthermore, cytotoxicity assessments indicated notable cytotoxicity effects of DOX-loaded Cu-MOF/Hep on MCF-7 cells (IC50: ~10 μg/mL in 48 h) with a significant apoptosis rate. The existence of CD44 receptors on the surfaces of cells underscores the significance of Hep-modified systems in facilitating the apoptosis of cancerous cells. The results suggest that the combined Cu-MOF and Hep have the potential to be a viable option for creating platforms that deliver anticancer treatments.

Topik & Kata Kunci

Penulis (9)

S

Sima Darvishi

H

Hossein Hosseinzadeh

F

Fahimeh Kazeminava

A

Amin Mahoutforoush

M

Mohammadreza Tajik

M

Monireh Rasoulzadehzali

R

Reza Mohammadi

S

S. Sadjadi

S

Siamak Javanbakht

Format Sitasi

Darvishi, S., Hosseinzadeh, H., Kazeminava, F., Mahoutforoush, A., Tajik, M., Rasoulzadehzali, M. et al. (2024). Heparin-functionalized Cu-based metal-organic framework: An efficient active and passive targeting nanocarrier for anticancer doxorubicin drug delivery.. https://doi.org/10.1016/j.ijbiomac.2024.136648

Akses Cepat

Informasi Jurnal
Tahun Terbit
2024
Bahasa
en
Total Sitasi
27×
Sumber Database
Semantic Scholar
DOI
10.1016/j.ijbiomac.2024.136648
Akses
Open Access ✓